 
        Antibiotic Cement Coated Distal Femur Endoprosthesis in Tumor Surgery
 
                                                    Antibiotic Cement Coated Distal Femur Endoprosthesis in Tumor Surgery
The anti-infective outcomes of the distal femoral replacement coated with antibiotic cement in limb salvage surgery: A randomized clinical trial.
Medicine (Baltimore) . 2022 Jan 28;101(4):e28648.Synopsis
Thirty six patients with primary bone tumors of the distal femur undergoing limb salvage surgery and endoprosthetic reconstruction were randomized to receive a custom antibiotic cement coated prosthesis (n=16) or a standard prosthesis (n=18). The primary outcome of interest was periprosthetic joint infection. Secondary outcomes of interest function and patient survival. The antibiotic cement coate...
                To view the full content, login to your account,
or start your 30-day FREE Trial today.
            
            FREE TRIAL
            LOGIN
            Forgot Password?
    Explore some of our unlocked ACE Reports below!
 
                Learn about our AI Driven 
 High Impact Search Feature
     
    Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue 
                     
                 
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         LOGIN
                                    LOGIN
                                 
            
Join the Conversation
Please Login or Join to leave comments.